DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

MRI Homepage

MR could predict survival and treatment response for patients with brain metastasis May spare them life-threatening surgeries

New nanoparticle technology may replace MR for cancer detection Shows promise in preclinical study

Study finds bi-annual MR exams better option for young women with genetic risk Annual mammogram may not be necessary

Researchers develop MR technique to predict and prevent pregnancy complications Tracking water molecules to assess placenta health

Community practices not abiding by breast cancer screening guidelines for MR High breast density isn't enough

Mayo Clinic expert emphasizes safety demands of interventional MR procedures Ideal solution is a dedicated iMR site

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

Sectra announces MR and ultrasound monitoring capabilities for DoseTrack Will no longer be limited to information from ionizing sources

Expert makes the case for patient access to radiology reports Patients want a more active role in their care

GE debuts new flexible, blanket-like MR coils at RSNA Improves patient comfort during whole body exams

Catherine Limperopoulos

'Glaring void' in diagnostics prompts 3-D MR solution for life-threatening births

by John W. Mitchell , Senior Correspondent
Placenta abruption linked to preterm delivery occurs in 6.5 of every 1,000 births and correlates strongly with perinatal deaths.

Until recently, there was no reliable test to determine if a pregnant woman was at risk for the condition. But a team at Children's National Health System think they have discovered a machine-learning, 3-D MR solution to the problem that may eventually yield novel early biomarkers of placental failure.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit www.mvs.bayer.com to set up an order today.



"Placental failure is a major public health problem, with repercussions that extend across the lifespan, affecting the fetus, newborn, and child," Catherine Limperopoulos, Ph.D., co-director of research in the Division of Neonatology, Children's National Health System, told HCB News. "Placental dysfunction can result in fetal and neonatal death, preterm birth, fetal growth restriction and long-term neurodevelopmental morbidity."

The study results were just published in the most recent issue of the Journal of Magnetic Resonance Imaging.

"To date, no study has proposed a framework (or platform) such as the one we describe in the current study that utilizes a multi-dimensional MR texture-based approach to measure placental shape and textural features, and evaluate that framework's ability to predict placental maturity reliably, identify fetal growth restriction in utero and predict postnatal birth weight ," she explained.

The Children's research team acquired 124 3-D MR fetal scans from 80 pregnancies beginning at the 18th gestational week and continuing through the 39th gestational week. Forty-six women had normal pregnancies and healthy fetuses while 34 women's pregnancies were complicated by fetal growth restriction (FGR), defined by estimated fetal weight that fell below the 10th percentile for gestational age.

The 3-D MR scans characterized placentas by shape, volume, morphometry, and texture. A machine-learning-based framework distinguished healthy pregnancies from FGR pregnancies with 86 percent accuracy and 87 percent specificity. And it estimated the birth weight in both healthy and high-risk fetuses throughout the second half of gestation reasonably well.

"Currently, a major obstacle to identifying placental dysfunction is the lack of early in vivo biomarkers of imminent placental failure," said Limperopoulos. "This problem is further compounded by the glaring void in diagnostic techniques for truly informed and effective fetal-placental monitoring."

She added that current techniques, such as ultrasound, Doppler, and biophysical profile, cannot provide direct measures of placental (and fetal) well-being. At best, she noted, these techniques provide surrogate measures that lack sensitivity and specificity.

"The recent successful application of medical AI holds the promise of supporting the development of novel biomarkers to identify high-risk pregnancies," said Limperopoulos.

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED